Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers

@article{Lam2016CombatingMG,
  title={Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers},
  author={Shu Jie Lam and Neil M. O’Brien-Simpson and Namfon Pantarat and Adrian Sulistio and Edgar H. H. Wong and Yu-Yen Chen and Jason C. Lenzo and James Austin Holden and Anton Blencowe and Eric C. Reynolds and Greg Guanghua Qiao},
  journal={Nature Microbiology},
  year={2016},
  volume={1}
}
With the recent emergence of reports on resistant Gram-negative ‘superbugs’, infections caused by multidrug-resistant (MDR) Gram-negative bacteria have been named as one of the most urgent global health threats due to the lack of effective and biocompatible drugs. [] Key Result Here, we show that a class of antimicrobial agents, termed ‘structurally nanoengineered antimicrobial peptide polymers’ (SNAPPs) exhibit sub-μM activity against all Gram-negative bacteria tested, including ESKAPE and colistin…
View on Nature
ncbi.nlm.nih.gov
447 Citations
Highly Influential Citations
9
Background Citations
52
Methods Citations
3
Results Citations
1

447 Citations

Antimicrobial drugs: Multifaceted approach to multidrug resistance
TLDR
In vitro, S16 and S32 showed antimicrobial efficacy against a range of bacteria, with preferential activity against Gram-negative species, and their multimodal action should help to slow or prevent the development of resistance.
A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
TLDR
Antibiotic adjuvant peptide SLAP-S25 binds to the inner and outer membranes of Gram-negative bacteria to cause membrane damage and boost efficacy of all major antibiotic classes.
Star-Peptide Polymers are Multi-Drug-Resistant Gram-Positive Bacteria Killers.
TLDR
It is shown that the star-peptide polymers preferentially target and kill Gram-positive pathogens including MRSA, which highlights the potential utility of peptide/polymers to fabricate materials for therapeutic development against MDR Gram- positive bacterial infections.
Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
A polymeric approach toward resistance-resistant antimicrobial agent with dual-selective mechanisms of action
TLDR
The oligomer exhibited excellent effectiveness in various model systems, killing extracellular or intracellular bacteria in the presence of mammalian cells, removing all bacteria from Caenorhabditis elegans, and rescuing mice with severe infections.
A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset
TLDR
These biodegradable synthetic macromolecules have been demonstrated to have broad spectrum in vivo antimicrobial activity, and have excellent potential as systemic antimicrobials against MDR infections.
Antimicrobial peptide polymers: no escape to ESKAPE pathogens—a review
TLDR
The novel techniques utilizing the bacteriolytic activity of natural AMPs and the effective localization of these peptides onto the negatively charged bacterial surface by using nanocarriers and structurally nanoengineered antimicrobial peptide polymers (SNAPPs) owing to its smaller size and better antimicrobial activity are described.
Polyprodrug Antimicrobials: Remarkable Membrane Damage and Concurrent Drug Release to Combat Antibiotic Resistance of Methicillin-Resistant Staphylococcus aureus.
TLDR
No detectable resistance is observed for polyprodrug antimicrobials against MRSA, which is demonstrated to be better than commercial triclosan and vancomycin against in vivo MRSA-infected burn models and a promising approach to the hurdle of antibiotic resistance in biomedicine.
Host Defense Peptide Mimicking Peptide Polymer Exerting Fast, Broad Spectrum and Potent Activities towards Clinically Isolated Multidrug-Resistant Bacteria.
TLDR
The peptide polymer's potent and broad spectrum antimicrobial activities against MDR bacteria in vitro and in vivo, resistance to proteolysis, and high structural diversity all together imply a great potential of peptides 80:20 DM:Bu in antimicrobial applications, as synthetic mimics of host defense peptides.
Antimicrobial Peptides and Macromolecules for Combating Microbial Infections: From Agents to Interfaces.
Bacterial resistance caused by the overuse of antibiotics and the shelter of biofilms has evolved into a global health crisis, which drives researchers to continuously explore antimicrobial molecules…
...
...

References

SHOWING 1-10 OF 70 REFERENCES
Combating multidrug-resistant Gram-negative bacterial infections
TLDR
This review provides an overview of recent R&D activities in the search for novel antibiotics against MDR Gram-negatives and examines new analogs of existing antibiotic molecules as well as agents against novel bacterial targets such as aminoacyl–tRNA synthetase and peptide deformylase.
Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria
TLDR
This work shows that silver can be used to enhance the action of existing antibiotics against Gram-negative bacteria, thus strengthening the antibiotic arsenal for fighting bacterial infections.
Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria
TLDR
Proline-rich antimicrobial peptides display the ability to not only modulate the immune system via cytokine activity or angiogenesis but also possess properties of penetrating cell membranes and crossing the blood brain barrier suggesting a role as potential novel carriers.
Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences.
  • R. Siegel
  • Medicine, Biology
    Respiratory care
  • 2008
TLDR
There is urgent need to employ strategies that will slow the development of resistance to the current armamentarium, such as avoiding prolonged antibiotic use or under-dosing, using pharmacokinetic and pharmacodynamic principles to choose dosing regimens, and encouraging early and aggressive empirical therapy.
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides.
TLDR
It is found that anionic CPSs, but not cationic or uncharged ones, blocked the bactericidal activity of APs by binding them, thereby reducing the amount of peptides reaching the bacterial surface.
Escherichia coli Cell Surface Perturbation and Disruption Induced by Antimicrobial Peptides BP100 and pepR*
TLDR
The mechanisms adopted by two AMPs in disrupting the Gram-negative Escherichia coli bacterial envelope were explored and the hypothesis that surface neutralization occurs close to MIC values was confirmed.
Biodegradable nanostructures with selective lysis of microbial membranes.
TLDR
It is demonstrated that the nanoparticles disrupt microbial walls/membranes selectively and efficiently, thus inhibiting the growth of Gram-positive bacteria, methicillin-resistant Staphylococcus aureus (MRSA) and fungi, without inducing significant haemolysis over a wide range of concentrations.
Resistance to antimicrobial peptides in Gram-negative bacteria.
TLDR
These mechanisms play an important role in bacterial resistance to host-derived AMPs that are encountered during the course of infection and should be taken into consideration in the development and use of AMPs as anti-infective agents.
Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides
TLDR
The characterization of a novel mechanism of resistance to APs that is dependent on the bacterial capsule polysaccharide (CPS) is reported, suggesting that CPS protects bacteria by limiting the interaction of APs with the surface.
Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent.
TLDR
It is shown that a novel class of core-shell nanoparticles formed by self-assembly of an amphiphilic peptide have strong antimicrobial properties against a range of bacteria, yeasts and fungi and can cross the blood-brain barrier and suppress bacterial growth in infected brains.
...
...